Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.

被引：0
|
作者：
Wang, Z. [1 ]
Han, Z. [1 ]
Tao, J. [1 ]
Chen, H. [1 ]
Sun, L. [1 ]
Tan, R. [1 ]
Gu, M. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Urol, Nanjing, Jiangsu, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B125
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [21] INFLUENCE OF CYP3A5, CYP2C8 AND ABCB1 POLYMORPHISMS ON TACROLIMUS-INDUCED NEPHROTOXICITY IN LIVER TRANSPLANT RECIPIENTS
    Shi, Yunying
    Tang, Jiangtao
    Zhang, Junlong
    An, Yunfei
    Liao, Yun
    Li, Yi
    Tao, Ye
    Wang, Lanlan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 122 - 122
  • [22] Roles of CYP3A4, CYP3A5 and CYP2C8 drug-metabolizing enzymes in cellular cytostatic resistance
    Hofman, Jakub
    Vagiannis, Dimitrios
    Chen, Si
    Guo, Lei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 340
  • [23] Effect of SHR0302 on the pharmacokinetics of CYP3A4, CYP2C8, CYP2C9 and CYP2C19 probe substrates in healthy volunteers: A cocktail analysis
    Fu, Meng
    Luo, Lin
    Feng, Sheng
    Lin, Hongda
    Lu, Zekun
    Gu, Fei
    Fan, Yang
    Wu, Bing
    Huang, Jianying
    Shen, Kai
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (12) : 3659 - 3668
  • [24] Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro:: Potential for interactions with CYP2C8 inhibitors
    Jaakkola, Tiina
    Laitila, Jouko
    Neuvonen, Pertti J.
    Backman, Janne T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (01) : 44 - 51
  • [25] PHARMACOKINETICS OF CIPROFLOXACIN IN ASIANS WITH DIFFERENT CYP2C19 AND CYP3A5 GENOTYPES
    Zhao, Bin
    Moochhala, Shabbir
    Lu, Jia
    Yap, Eric
    Goh, Boon Cher
    Lee, How Sung
    Lai, Mui Hoon
    Tan, Lili
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 : 35 - 35
  • [26] Influence of CYP3A4*22 and CYP3A5*3 genetic polymorphisms on tacrolimus pharmacokinetics in adult renal transplant patients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S709 - S709
  • [27] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [28] Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population
    Adehin, Ayorinde
    Bolaji, Oluseye Oladotun
    Kennedy, Martin A.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (03) : 189 - 191
  • [29] Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry
    Falzoi, Matteo
    Mossa, Alessandra
    Congeddu, Elena
    Saba, Luisella
    Pani, Luca
    PHARMACOGENOMICS, 2010, 11 (04) : 559 - 571
  • [30] Lack of Tacrolimus Circadian Pharmacokinetics and CYP3A5 Pharmacogenetics in the Early and Maintenance Stages in Renal Transplant Recipients.
    Satoh, Shigeru
    Saito, Mitsuru
    Kagaya, Hideaki
    Miura, Masatomo
    Inoue, Takamitsu
    Miura, Yoshio
    Numakura, Kazuyuki
    Kumazawa, Teruaki
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 590 - 590
12345